US Brand Name(s) of Mitomycin: Jelmyto
Use in Cancer Treatment
Mitomycin is for usage alone or in combination with other medications to treat:
Locally progressed or metastasized gastric (stomach) and pancreatic adenocarcinoma (spread to other parts of the body). It is for people whose illness hasn’t improved after other treatments.
Urothelial carcinoma of the urethra is a kind of cancer that affects the lining of the urinary system. As a therapy for individuals with low-grade illness, it is injected straight into the ureter or kidney. Mitomycin under the trade name Jelmyto has approval for this purpose.
Mitomycin is also under research for use in the treatment of various cancers.
Detailed scientific definition – Definition from the NCI Drug Dictionary
Mitomycin and Mitomycin Pyelocalyceal
Layman language summaries of key information about these medicines from MedlinePlus. The following are examples of MedlinePlus information:
- Cautions about this medicine
- What is the use and how?
- Whom should you consult before taking it?
- What you should know about it before using it?
- Other drugs that might interact with it
- Possible negative effects
Drugs are frequently under research to see whether they can assist treat or prevent conditions other than those already prevalent. This patient information leaflet covers uses which have been under authorization. Much of the material, though, might also apply to authorized uses that are being investigated.
